
Scientists rejoice as British trees evolve resistance to devastating ash dieback fungus
Britain's trees are evolving resistance to the deadly ash dieback fungus, scientists have revealed.
The disease, which arrived in Britain in 2012, has wrought havoc on the countryside, leaving behind the skeletal remains of dying ash trees.
Previous estimates predict that up to 85 per cent of ash trees will succumb to the disease, and COBRA have held emergency meetings about how to deal with the issue.
But now, experts have discovered that a new generation of ash trees, growing naturally in woodland, exhibit greater resistance to the disease compared to older trees.
They found that natural selection is acting upon thousands of locations within ash tree DNA, driving the evolution of resistance.
The study provides a real-world example of natural selection in action, they said.
And it offers renewed hope for the future of ash trees in Britain.
'Thanks to natural selection, future generations of ash should have a better chance of withstanding infection,' Dr Carey Metheringham, from Queen Mary University of London (QMUL) said.
Ash dieback, which arrived in Britain in 2012, has wrought havoc on the countryside, leaving behind skeletal remains of dying ash trees. Pictured: The effects of the disease in the Hughenden Estate, Buckinghamshire
Ash dieback is caused by the fungus Hymenoscyphus fraxineus, which originated in Asia.
The new study, published in the journal Science, focused on Marden Park wood in Surrey, a semi-natural ancient woodland dominated by ash.
Researchers compared the DNA of ash trees established before and after the fungal invasion reached Britain.
They found shifts in variants associated with tree health in thousands of places across the overall genome of the trees.
The findings indicate younger generations of trees have greater resistance to the fungus, they said.
And it could mean ash does not go the same way as elm trees, which have been largely lost from the British landscape as a result of Dutch elm disease, although breeding programmes may be needed to bolster the fightback.
'Natural selection alone may not be enough to produce fully resistant trees,' Dr Metheringham added.
'The existing genetic variation in the ash population may be too low, and as the trees become scarcer, the rate of selection could slow.
'Human intervention, such as selective breeding and the protection of young trees from deer grazing, may be required to accelerate evolutionary change.'
Another of the study's authors, Professor Richard Buggs, from the Royal Botanic Gardens at Kew and Queen Mary, said: 'We are so glad that these findings suggest that ash will not go the way of the elm in Britain.
'Elm trees have struggled to evolve to Dutch elm disease, but ash are showing a very different dynamic because they produce an abundance of seedlings upon which natural selection can act when they are still young.
'Through the death of millions of ash trees, a more resistant population of ash is appearing.'
Rebecca Gosling, from the Woodland Trust which owns and manages Marden Park wood, said: 'Ash dieback demonstrates how devastating introduced pathogens can be for our trees and the species which rely upon them.
'This important research gives us hope for the future of our ash populations.'
She added: 'The findings highlight how vital it is to support natural regeneration in woodlands, furthering our understanding of how to best manage our ash woodlands.'
The study was mainly funded by the Environment Department (Defra) whose chief plant health officer Professor Nicola Spence said it demonstrated that tolerance to ash dieback can be inherited, and breeding programmes and natural regeneration together could secure the future of native ash.
Previously, the Woodland Trust has estimated that more than 100 million ash trees are expected to be lost to ash dieback, at a cost of over £15 billion.
The disease blocks water systems and causes leaves to wilt, shoots to die, lesions on branches and eventually the death of the tree.
Last year, scientists announced they were working on gene-edited saplings that are immune to ash dieback.
And since the initial crisis more than a decade ago, there has been a nationwide overhaul of how the government approaches plant diseases.
ASH DIEBACK EXPLAINED
Ash dieback affects ash trees (Fraxinus excelsior) and is caused by the fungus Hymenoscyphus fraxineus, previously known by the names Chalara fraxinea and Hymenoschyphus pseudoalbidus).
It blocks the water transport systems in trees causing leaf loss, lesions in the wood and on the bark and ultimately the dieback of the crown of the tree.
This disease was first described in Poland in 1992 and has since swept westwards throughout Europe.
It was first identified in Britain in 2012 in nursery stock then in the wider environment in 2013 although it could have been in the country much longer.
The number of confirmed findings is continuing to increase and the distribution is reported by the Forestry Commission on a regular basis.
Young trees are particularly vulnerable and die quickly once they succumb. Older trees can be slowly killed by a yearly cycle of infection.
Spread of the disease in the UK is most likely to be as a result of the planting of infected nursery stock and wood but wind borne distribution of the fungal spores also occurs.
There are several key signs to look out for on ash trees. All of these symptoms can also be caused by other problems, so final diagnosis should be made by an expert.
Summer is a good time to look for symptoms as in autumn and winter, ash trees will naturally be shedding their leaves making it difficult to identify ash dieback.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
6 hours ago
- Daily Mail
How plaque and gum disease can lead to dementia: As doctors unveil startling research, experts reveal ultimate guide to the brushes, floss and toothpaste that really work to keep you healthy
If eyes are the window to the soul, then the mouth is a portal to the mind, according to the British Dental Association. 'There's emerging evidence that poor oral health – plaque formation, gum disease and tooth loss – is a risk factor for dementia, including Alzheimer's disease,' says Eddie Crouch, the association's chair. A slew of recent research suggests that what happens in your mouth can have wider health implications. Several large studies have discovered links between periodontitis (that's chronic gum disease to you and me) and an increased risk of cognitive decline.


Telegraph
6 hours ago
- Telegraph
The British Medical Association has just shown its contempt for science
The British Medical Association hasn't gone out of its way to court public affection lately – the 11 strikes the BMA has held since 2022 resulted in about 1.5 million cancelled appointments, though they also resulted in an astonishing increase in its members' pay. And it's a safe bet that patients won't be edified to learn that they're now 'energised' at the prospect of yet another strike. But if the doctors' union is disastrously out of touch on strikes, it turns out that it's even more remote from public opinion on the contentious trans issue. The Cass Review recommended an almost complete ban on puberty blockers for children. Well, the man who led the BMA's opposition to the Report, Tom Dolphin, has now been made chairman of the BMA's council, its governing body. The appointment followed what looks like a coup by the 69 member board which ousted the previous incumbent, Professor Philip Banfield. Dr Dolphin tabled an emergency motion last July that led to the union rejecting the Cass report. It announced it would be publishing its own review instead. But alas, nothing has so far appeared. Let's remember that Hilary Cass, the author of the report, found that 'there is no good evidence' that puberty blockers for young people are safe to use and that 'it is unusual for us to give a potentially life-changing treatment to young people and not know what happens to them in adulthood'. And it seems that in fact many doctors agreed. When the BMA council bypassed debate to reject the Cass review after it ran out of time to discuss the motion at the annual meeting, there were four attempts by members to have an open debate on the review. More than 1,500 doctors, the majority of them BMA members, signed a 'Not in Our Name' open letter to the BMA council, criticising the 'very undemocratic' decision to reject Lady Cass's findings. But rather than respond to members' concerns, the BMA council has now elected Tom Dolphin to lead the organisation. It's not out to please, is it? Dr Dolphin's view on this issue can be judged by his position three years ago, when he posted photos of himself getting ready for a Trans Pride march, saying: 'About to set off to let London know that trans rights are human rights!' Mind you, he didn't focus on this when he accepted his new position, observing that the last three years 'has been a period of huge change for the BMA which has seen doctors realise the power that they have as trade union members to change their working lives … for the better. The fight to restore doctors' pay and pensions continues.' More militancy then. You have to ask: are doctors really best led by a man who takes such a radical approach to giving life-altering drugs to children confused about their gender? I'd say it's proof that the BMA isn't an organisation that patients or the Government can take seriously.


Daily Mail
7 hours ago
- Daily Mail
The drink that could lengthen your lifespan - and is linked to a lower risk of dementia, diabetes and heart disease
Drinking coffee might not only perk you up, it may even help you live longer, scientists suggest. Experts found caffeine—the component of the morning favourite that gives it stimulating powers—influenced how cells grow, repair and respond to stress. This, British researchers said, could provide some major potential benefits to longevity and explain how it wards off major killers like dementia, diabetes and heart failure. In lab tests, the team found caffeine triggered cells to enter an energy restoration system scientists call AMPK (AMP-activated protein kinase). AMPK, an enzyme, acts similar to the fuel gauge in a car. When energy levels in a cell get too low, AMPK kicks in, triggering a series of reactions that help protect and repair it. Cells more able to access this system age slower, can repair DNA more effectively and respond better to stress, factors tied to combating ageing and disease. The team, from Queen Mary University, London, said this process could explain why drinking coffee has been linked to a lower risk of serious health conditions and a prolonged lifespan. Dr John-Patrick Alao, an expert in cell biology and lead scientist of the study, explained: 'These findings help explain why caffeine might be beneficial for health and longevity'. He added that the research also opened the door to developing drugs and therapies which could be used activate the same system in the future. In the study, published in the journal Microbial Cell, the team analysed how a type of yeast with similar properties to human cells—responded to caffeine. The research is the latest to highlight the potential health benefits of coffee. Earlier this month, US researchers found coffee lovers tended to have healthier hearts, putting them at lower risk of cardiac death. Experts from Tufts University, Boston, found that people who drank between two and three cups of black coffee a day, saw the most benefits, slashing their risk by almost a fifth. Other research has linked regular coffee consumption to a lower risk of depression, better liver health, improved weight loss and reduced odds of developing conditions like type 2 diabetes and dementia. Scientists are still working to understand exactly how coffee achieves its health boosting effects. While some—like the recent research point to caffeine—others highlight how the drink is rich in polyphenols, natural plant compounds with antioxidant properties that protect cell health, as another potential mechanism. But it's not all good news for coffee lovers. Other studies have linked coffee consumption to vision problems, increased risk of certain cancers, and heart disease. The NHS itself warns Britons that consuming more than four cups a day could lead to a dangerous increase in blood pressure, increasing the risk of serious problems like heart attack, stroke and even dementia. Experts have said part of the problem with unpicking the potential health benefits and risks of coffee consumption is the variety of ways people prepare and drink it. Some studies have found particular risks and boons are linked to if the coffee is instant or freshly brewed or if it is filtered. Another complicating factor is what people have with their coffee, if they add sugar, milk or flavoured syrups as well as how many cups they have per day. Heart disease and dementia, two health conditions coffee may protect against, are some of biggest killers in Britain. Approximately, 170,000 Britons die from heart and circulatory diseases combined per year in the UK, according to the British heart Foundation. This is equivalent to about 480 fatalities per day or roughly a quarter of all deaths. The most recent data suggests 74,261 people died from dementia in 2022, making it the biggest killer by single cause of death.